Insider Transactions in Q1 2023 at Coya Therapeutics, Inc. (COYA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2023
|
Dov A Md Goldstein Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Anabella Villalobos Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
David S Snyder Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
-
|
|
Jan 03
2023
|
Hideki Garren Director |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
-
|
|
Jan 03
2023
|
Adrian Hepner Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Ann Lee Director |
BUY
Conversion of derivative security
|
Direct |
6,479
+28.22%
|
$25,916
$4.0 P/Share
|
|
Jan 03
2023
|
Ann Lee Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|
|
Jan 03
2023
|
Howard Berman Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
-
|